Clinical trial DRKS00013177
Status: Recruiting (according to the registry)Phase not statedLatest change: Source: DRKS (Germany) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in June 25, 2019 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Observation of CBD therapy inpatients with intractable epilepsy
- Record number
- DRKS00013177
- Registry
- DRKS (Germany) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase not stated
- Participants
- Target: 40
- Condition (as registered)
- Epilepsy
- Countries
- Germany
- Topic in the guide
- Drug-Resistant Epilepsy
Timeline
According to the DRKS (Germany) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: June 25, 2019
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Drug-Resistant Epilepsy: guide page · Thinking of taking part? Which specialist to see